{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:31:24Z","timestamp":1792211484822,"version":"4.4.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>An 80-year-old man with metastatic melanoma had been receiving treatment with pembrolizumab from September 2015 until June 2017. Series FDG PET\/CT scans from March 7, 2017, to June 14, 2018, showed the course of biopsy-proven pembrolizumab-induced sarcoidosis. Reported here is the first case of multiorgan sarcoidosis induced by pembrolizumab and its self-resolving course on FDG PET\/CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002408","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T06:36:12Z","timestamp":1543991772000},"page":"167-168","source":"Crossref","is-referenced-by-count":24,"title":["FDG PET\/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis"],"prefix":"10.1097","volume":"44","author":[{"given":"Yang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jdcr.2016.06.004","article-title":"Pembrolizumab-associated sarcoidosis","volume":"2","year":"2016","journal-title":"JAAD Case Rep"},{"key":"bib2-20230928","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/annonc\/mdw125","article-title":"Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JOP.2017.027383","article-title":"Pembrolizumab-related sarcoid-like reaction presenting as reactivation of quiescent scars","volume":"14","year":"2018","journal-title":"J Oncol Pract"},{"key":"bib4-20230928","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-018-0323-0","article-title":"Granulomatous\/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients","volume":"6","year":"2018","journal-title":"J Immunother Cancer"},{"key":"bib5-20230928","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/RLU.0000000000001735","article-title":"Multiorgan involvement of chemotherapy-induced sarcoidosis mimicking progression of lymphoma on FDG PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20230928","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2169\/internalmedicine.53.3333","article-title":"Sarcoidosis mimicking metastatic breast cancer on FDG PET\/CT","volume":"53","year":"2014","journal-title":"Intern Med"},{"key":"bib7-20230928","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/17425255.2016.1120287","article-title":"New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors","volume":"12","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"bib8-20230928","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/1078155216667635","article-title":"Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors","volume":"23","year":"2017","journal-title":"J Oncol Pharm Pract"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201902000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:19:18Z","timestamp":1695871158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201902000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002408","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}